Gould Robert J's Form 4 filing
Fulcrum Therapeutics, Inc. (FULC) · filed Apr 5, 2022
- Accession no.
- 0000899243-22-013881
- Filed
- Apr 5, 2022
- Trade date
- Apr 1-5, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.28M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gould Robert JCIK 0001577034 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseAcquired | +34,464 | $7.84 | +$270,197.76 | 541,094 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −34,464 | $24.03 | −$828,169.92 | 506,630 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseAcquired | +7,235 | $7.84 | +$56,722.4 | 513,865 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −7,235 | $24.02 | −$173,784.7 | 506,630 | Direct | |
| Apr 5, 2022 | Common Stock | MOption exerciseAcquired | +52,552 | $7.84 | +$412,007.68 | 559,182 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −52,552 | $24.26 | −$1,274,911.52 | 506,630 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseDisposed | −34,464 | $0.00 | $0 | 289,998 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseDisposed | −7,235 | $0.00 | $0 | 282,763 | Direct | |
| Apr 5, 2022 | Common Stock | MOption exerciseDisposed | −52,552 | $0.00 | $0 | 230,211 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.